# Lymph Node Microenvironment Modifications in Patients With CLL Treated With Venetoclax-based Regimens

> **NCT04790045** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Paolo Ghia** · enrollment: 30 (estimated)

## Conditions studied

- Chronic Lymphocytic Leukemia

## Interventions

- **DRUG:** Venetoclax

## Key facts

- **NCT ID:** NCT04790045
- **Lead sponsor:** Paolo Ghia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-11-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04790045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04790045, "Lymph Node Microenvironment Modifications in Patients With CLL Treated With Venetoclax-based Regimens". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04790045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*